Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | +1.35% | +8.90% | -58.09% |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 6.17B | Sales 2025 * | 7.75B | Capitalization | 2.16B |
---|---|---|---|---|---|
Net income 2024 * | -145M | Net income 2025 * | -44M | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | 261M | Net cash position 2025 * | 230M | EV / Sales 2025 * | 0.25 x |
P/E ratio 2024 * |
-14.6
x | P/E ratio 2025 * |
-32.4
x | Employees | 1,117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.06% |
Latest transcript on agilon health, inc.
1 day | +1.35% | ||
1 week | +8.90% | ||
Current month | -4.36% | ||
1 month | -5.40% | ||
3 months | -22.87% | ||
6 months | -54.93% | ||
Current year | -58.09% |
Managers | Title | Age | Since |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 15-12-31 |
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Ronald Williams
FOU | Founder | 74 | 15-12-31 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 5.26 | +1.35% | 3,976,628 |
24-05-08 | 5.19 | +4.22% | 7,729,156 |
24-05-07 | 4.98 | +3.11% | 4,519,261 |
24-05-06 | 4.83 | 0.00% | 2,974,531 |
24-05-03 | 4.83 | 0.00% | 3,995,953 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.09% | 2.16B | |
-16.61% | 3.09B | |
-12.96% | 2.95B | |
+5.57% | 234M | |
-45.91% | 174M | |
-32.40% | 115M |
- Stock Market
- Equities
- AGL Stock